Archives of Pediatric Infectious Diseases

Published by: Kowsar

Acellular Pertussis Vaccine: Iran’s Next Step to Control the Disease?

Iraj Sedighi 1 , * and Taravat Sadrosadat 2
Authors Information
1 Department of Pediatrics, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Pediatrics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: April 2015, 3 (2); e59844
  • Published Online: April 15, 2015
  • Article Type: Editorial
  • Received: September 26, 2014
  • Revised: January 12, 2015
  • Accepted: January 25, 2015
  • DOI: 10.5812/pedinfect.23918

To Cite: Sedighi I, Sadrosadat T. Acellular Pertussis Vaccine: Iran’s Next Step to Control the Disease?, Arch Pediatr Infect Dis. 2015 ; 3(2):e59844. doi: 10.5812/pedinfect.23918.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Centers for Disease C. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60(41): 1424-6[PubMed]
  • 2. Long SS. Nelson text book of pediatrics. 2011; : 944-8
  • 3. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011; 52(2): 157-62[DOI][PubMed]
  • 4. Cherry JD. The present and future control of pertussis. Clin Infect Dis. 2010; 51(6): 663-7[DOI][PubMed]
  • 5. Hashemi SH, Ranjbar M, Hajilooi M, Seif-Rabiei MA, Bolandi M, Moghimi J. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis. 2009; 9: 58[DOI][PubMed]
  • 6. Hajia M, Rahbar M, Fallah F, Safadel N. Detection of Bordetella pertussis in Infants Suspected to have Whooping Cough. Open Respir Med J. 2012; 6: 34-6[DOI][PubMed]
  • 7. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis. 2010; 14(12)-5[DOI][PubMed]
  • 8. Hashemi SH, Zamani M, Mamani M, Javedanpoor R, Rahighi AH, Nadi E. Seroprevalence of Bordetella pertussis antibody in pregnant women in Iran. J Res Health Sci. 2014; 14(2): 128-31[PubMed]
  • 9. Sedighi I, Rahimi H, Emadoleslami MS, Fahimzad A, Hosseini F, Afsharian M, et al. Seroepidemiology of Bordetella pertussis Infection in Fresh College Students in Iran: A Multicenter Study. Arch Clin Infect Dis. 2014; 9(1)[DOI]
  • 10. Sedighi I, Sadrosadat T. Comment on: Seroprevalence of Bordetella pertussis Antibody in Pregnant Women in Iran. J Res Health Sci. 2014; 14(3): 236-7[PubMed]
  • 11. Healy CM, Rench MA, Castagnini LA, Baker CJ. Pertussis immunization in a high-risk postpartum population. Vaccine. 2009; 27(41): 5599-602[DOI][PubMed]
  • 12. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013; 131(6)-22[DOI][PubMed]
  • 13. Shokrollahi MR, Noorbakhsh S, Eizadi A, Monavari HR, Mousavi MJ, Javad Nia S, et al. Searching the B. pertussis (Real Time PCR) in Cases with Prolonged Cough (>2 weeks) in Population with Unvaccinated Adult: A Cross Sectional Study. Tehran, Iran. J Community Med Health Educ. 2013; 3: 202[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments